Price Target

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours
Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours
Rocket Pharmaceuticals downgraded by BofA after FDA halts Danon disease trial; company pivots toward earlier-stage gene therapy programs.
Investor Reaction To Predictable Mobileye Earnings Was Negative: Analyst
Investor Reaction To Predictable Mobileye Earnings Was Negative: Analyst
Analyst reiterates buy rating on Mobileye (MBLY) with $18 price target. Stock traded lower due to conservative Q4 outlook, but Q3 guidance beat consensus.
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance
Edwards Lifesciences beat Q2 estimates and raised its 2025 sales outlook as TAVR and TMTT segments drove double-digit revenue growth.
Southwest's Rocky Q3 Outlook Sparks Doubts Over Steep Q4 Profit Climb
Southwest's Rocky Q3 Outlook Sparks Doubts Over Steep Q4 Profit Climb
Southwest's weak Q3 outlook and steep Q4 revenue targets raise concerns over its ability to meet full-year profitability goals.
Coursera's Upbeat Outlook Drives Stock Higher
Coursera's Upbeat Outlook Drives Stock Higher
Coursera shares soar over 32% as strong Q2 results and rising consumer momentum boost long-term growth expectations.
Union Pacific's Turnaround Gains Momentum With Stellar Q2 Operations
Union Pacific's Turnaround Gains Momentum With Stellar Q2 Operations
Union Pacific Corp. (NYSE: UNP) is showing strong growth in operations and finances, supported by productivity gains and a earnings beat. Analysts raise price forecast and see potential for merger with Norfolk Southern.
Why Palantir Is The 'AI All-Star' You Need To Watch
Why Palantir Is The 'AI All-Star' You Need To Watch
Palantir gains spotlight as it eyes a $24B revenue future, fueled by AI momentum, margin strength, and rising defense tech prominence.
These Analysts Boost Their Forecasts On TechnipFMC Following Upbeat Q2 Earnings
These Analysts Boost Their Forecasts On TechnipFMC Following Upbeat Q2 Earnings
Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results
Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results
Dow Analysts Slash Their Forecasts After Weak Q2 Results
Dow Analysts Slash Their Forecasts After Weak Q2 Results
Imax Analysts Increase Their Forecasts After Q2 Results
Imax Analysts Increase Their Forecasts After Q2 Results
These Analysts Raise Their Forecasts On Blackstone Following Q2 Earnings
These Analysts Raise Their Forecasts On Blackstone Following Q2 Earnings
Nasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday
Nasdaq To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday
Wall Street's Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 6% Dividend Yields
Wall Street's Most Accurate Analysts Weigh In On 3 Real Estate Stocks With Over 6% Dividend Yields
Charter Communications Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Charter Communications Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Top Wall Street Forecasters Revamp HCA Healthcare Expectations Ahead Of Q2 Earnings
Top Wall Street Forecasters Revamp HCA Healthcare Expectations Ahead Of Q2 Earnings
Centene Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Centene Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Nike And Jordan Power Academy Sports' Store Upgrade
Nike And Jordan Power Academy Sports' Store Upgrade
Academy Sports & Outdoors shares dip 2.8% as the company leans on enhanced merchandising, RFID rollout and operational upgrades to stabilize performance.
Pegasystems Affirms Outlook As Cloud Strategy Powers Momentum
Pegasystems Affirms Outlook As Cloud Strategy Powers Momentum
Pegasystems exceeded expectations in Q2 2025, with robust revenue and cloud growth. Analysts maintain a bullish outlook, raising price forecast.
Buy IBM Stock On 'Short-Term Weakness,' Analyst Asserts After Q2 Performance
Buy IBM Stock On 'Short-Term Weakness,' Analyst Asserts After Q2 Performance
Wedbush analyst maintains Outperform rating and $325 price forecast for IBM. Strong fiscal Q2 results and reaffirmed full-year guidance. AI book of business accelerates to $7.5 billion.
These Analysts Revise Their Forecasts On Northern Trust Following Q2 Earnings
These Analysts Revise Their Forecasts On Northern Trust Following Q2 Earnings
These Analysts Cut Their Forecasts On SEI Investments After Q2 Results
These Analysts Cut Their Forecasts On SEI Investments After Q2 Results
Tesla Stock Faces 'Critical Milestone' Ahead: Here's What Analysts Are Flagging As Next Key Catalyst
Tesla Stock Faces 'Critical Milestone' Ahead: Here's What Analysts Are Flagging As Next Key Catalyst
What's the next key moment for Tesla? Analysts highlight this item as the key from Q2 results and for the future of the company.

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved